Literature DB >> 12115678

Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice.

Christopher A Meade1, Yun-Ping Deng, Francesca R Fusco, Nobel Del Mar, Steven Hersch, Dan Goldowitz, Anton Reiner.   

Abstract

The cellular localization and development of neuronal intranuclear inclusions (NIIs) in cortex and striatum of R6/2 HD transgenic mice were studied to ascertain the relationship of NIIs to symptom formation in these mice and gain clues regarding the possible relationship of NII formation to neuropathology in Huntington's disease (HD). All NIIs observed in R6/2 mice were ubiquitinated, and no evidence was observed for a contribution to them from wild-type huntingtin; they were first observed in cortex and striatum at 3.5 weeks of age. In cortex, NIIs increased rapidly in size and prevalence after their appearance. Generally, cortical projection neurons developed NIIs more rapidly than cortical interneurons containing calbindin or parvalbumin. Few cortical somatostatinergic interneurons, however, formed NIIs. In striatum, calbindinergic projection neurons and parvalbuminergic interneurons rapidly formed NIIs, but they formed more gradually in cholinergic interneurons, and few somatostatinergic interneurons developed NIIs. Striatal NIIs tended to be smaller than those in cortex. The early accumulation of NIIs in cortex and striatum in R6/2 mice is consistent with the early appearance of motor and learning abnormalities in these mice, and the eventual pervasiveness of NIIs at ages at which severe abnormalities are evident is consistent with their contribution to a neuronal dysfunction underlying the abnormalities. That cortex develops larger NIIs than striatum, however, is inconsistent with the preferential loss of striatal neurons in HD but is consistent with recent evidence of early morphological abnormalities in cortical neurons in HD. That calbindinergic and parvalbuminergic striatal neurons develop large NIIs is consistent with a contribution of nuclear aggregate formation to their high degree of vulnerability in HD. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115678     DOI: 10.1002/cne.10295

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  42 in total

1.  Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex.

Authors:  Adam G Walker; Jason R Ummel; George V Rebec
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

2.  Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha.

Authors:  Elizabeth K Lucas; Sean J Markwardt; Swati Gupta; James H Meador-Woodruff; Jiandie D Lin; Linda Overstreet-Wadiche; Rita M Cowell
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis.

Authors:  Amy B Ryan; Scott O Zeitlin; Heidi Scrable
Journal:  Neurobiol Dis       Date:  2006-09-15       Impact factor: 5.996

4.  Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.

Authors:  Y P Deng; J P Xie; H B Wang; W L Lei; Q Chen; A Reiner
Journal:  J Chem Neuroanat       Date:  2007-03-04       Impact factor: 3.052

5.  Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

Authors:  Mohammad Mehdi Banoei; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Parvin Shariati; Maryam Rostami; Masoumeh Dehghan Manshadi; Tayebeh Majidizadeh
Journal:  Cell Mol Neurobiol       Date:  2007-10-20       Impact factor: 5.046

Review 6.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

Review 7.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

8.  Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.

Authors:  Birgit Zucker; Dagmar E Ludin; Thomas A Gerds; Carl H Lücking; G Bernhard Landwehrmeyer; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-30       Impact factor: 3.000

9.  Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.

Authors:  Damian M Cummings; Carlos Cepeda; Michael S Levine
Journal:  ASN Neuro       Date:  2010-06-18       Impact factor: 4.146

10.  Roles of KChIP1 in the regulation of GABA-mediated transmission and behavioral anxiety.

Authors:  Kun Xia; Hui Xiong; Yeonsook Shin; Danling Wang; Tom Deerinck; Hiroto Takahashi; Mark H Ellisman; Stuart A Lipton; Gang Tong; Giannina Descalzi; Dongxian Zhang; Min Zhuo; Zhuohua Zhang
Journal:  Mol Brain       Date:  2010-08-02       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.